HDAC1 and central nervous system cancer: Since HDAC inhibitors have been found to induce neuronal-like differentiation in glioma cells [9,10], and there are currently no reports on such effects related to the drug targets of parthenolide except HDAC1, we focused our attention on HDAC1.